Back

Designed Minibinders Rewire Receptor Signaling to Enable Functional Human Myogenic Reprogramming

Keshri, R.; Foreman, Z.; Barrett, P.; Robinson, A. J.; Reyes, G.; Phal, A. A.; Krishnakumar, A.; Narog, E.; Chiu, M.; Jain, S.; Wang, X.; Lee, D.; Exposit, M.; Abedi, M.; Smith, A. S. T.; Srivatsan, S. R.; Shendure, J.; Mathieu, J.; Mack, D. L.; Baker, D.; Ruohola-Baker, H.

2026-04-27 biochemistry
10.64898/2026.04.26.720818 bioRxiv
Show abstract

Sarcopenia, loss of muscle mass is a considerable health burden that demands immediate societal attention. Direct myogenic somatic cell reprogramming, a potential muscle regeneration method is constrained by an inability to control the signaling logic that governs cell fate. Here, we show that this barrier can be overcome using AI-designed receptor modulators. Screening de novo minibinders, we identify a synthetic protein cocktail, C6-DPC, that drives efficient human fibroblast-to-muscle transdifferentiation with robust structural and metabolic maturation. C6-DPC reprograms extracellular signaling by activating pro-myogenic FGFR1/2c pathways while suppressing anti-myogenic inputs through ALK1 and TGFBR2; targeted depletion of ALK1 is sufficient to lower the reprogramming barrier. Inflammatory signaling via gp130 emerges as a dominant checkpoint, and its inhibition further enhances conversion. Engineered tissues generate high twitch and tetanic forces in both wild-type and dystrophin-deficient human cells. These findings demonstrate that programmable synthetic ligands can rewrite receptor-level signaling to direct cell fate and enable functional tissue regeneration.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.